Daclatasvir 30mg tablets
- SNOMED code
26941111000001108- Active compound
- Daclatasvir
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Non-availability
- Actual Products not Available
- Non-availability date
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Daclatasvir dihydrochloride, ID: 712519008
— 30 mg
based on base substance
- Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd)
Daklinza 30mg tablets
- SNOMED code
26865411000001101- Supplier
- Bristol-Myers Squibb Pharmaceuticals Ltd
- Licensed as
- Medicines - MHRA/EMA
- Availability restrictions
- Not available
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Daklinza 30mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 28 tablet 2 x 14 tablets26865511000001102 ref. pack |
Discontinued
Legal category: POM | No Price Available previously: £8,172 | — |
| — |
Reference packs
Daclatasvir 30mg tablets 28 tablet
- SNOMED code
26864911000001105- Quantity and unit
- 28 tablet
- Packs